Stockscreener 앱 받기
5.44
2.06%
0.11
시장 영업 전:
5.50
0.06
+1.10%
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
Published on: 2025-08-11 01:03:10 - Newser
Is Evoke Pharma Inc. trending in predictive chart modelsLow Risk Trade Timing with Analysis Metrics - Newser
Using data filters to optimize entry into Evoke Pharma Inc.Triple Digit Gain Opportunity Watchlist - Newser
Evoke Pharma (EVOK) to Release Quarterly Earnings on Tuesday - Defense World
Can a trend reversal in Evoke Pharma Inc. lead to recoveryValue Holding Return Summary With Outlook - Newser
Why Evoke Pharma Inc. stock attracts strong analyst attentionExpert-Backed High Yield Stock Watchlist - Newser
Will Evoke Pharma Inc. stock go up in YEARFastest Growing Stocks to Watch - thegnnews.com
Using RSI to spot recovery in Evoke Pharma Inc.Short-Term Stock Trend Forecast Guide - Newser
Real time scanner hits for Evoke Pharma Inc. explainedHigh Probability Trade Outcome Prediction - Newser
Evoke Pharma Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Is Evoke Pharma Inc. a Top Dividend Stock to Watch in 2025AI-Based Signal Detection for Active Traders - Newser
Reviewing Sol-Gel Technologies (NASDAQ:SLGL) and Evoke Pharma (NASDAQ:EVOK) - Defense World
Evoke Pharma's GIMOTI Patent Extended to 2038 Through New Patent Issuance - AInvest
Evoke Pharma's GIMOTI Patent Extended To 2038 Following New Patent Issuance - Nasdaq
Evoke Pharma announces issuance of new U.S. patent for GIMOTI - TipRanks
Evoke Pharma Secures New U.S. Patent for GIMOTI® - TipRanks
Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI Wi - GuruFocus
Evoke Pharma's Extended Market Exclusivity for GIMOTI: A Strategic IP and Regulatory Triumph for Long-Term Growth - AInvest
Evoke Pharma Announces Issuance Of New U.S. Patent For Gimoti With Extended Exclusivity To Late 2038 - TradingView
Evoke Pharma, Inc. Announces New U.S. Patent for GIMOTI® with Extended Market Exclusivity to November 2038 - Quiver Quantitative
Evoke Pharma extends GIMOTI patent protection until 2038 - Investing.com
Evoke Pharma extends GIMOTI patent protection until 2038 By Investing.com - Investing.com Nigeria
GIMOTI Gastroparesis Treatment Secures 2-Year Patent Extension, Strengthening Market Position Through 2038 - Stock Titan
How sentiment analysis helps forecast Evoke Pharma Inc.Stable Profit Zone and Loss Control Analysis - Newser
Applying chart zones and confluence areas to Evoke Pharma Inc.Watchlist Generator for Smart Money Signals - Newser
What makes Evoke Pharma Inc. stock price move sharplyPattern Breakout Prediction for Short Term - Newser
Visualizing Evoke Pharma Inc. stock with heatmapsSecure Buy Strategy Based on Risk Parameters - Newser
Elliott Wave Theory Predicts Pullback in Evoke Pharma Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
How does Evoke Pharma Inc. compare to its industry peersBuild a diversified portfolio for stability - Jammu Links News
What analysts say about Evoke Pharma Inc. stockHigh-octane gains - Jammu Links News
Is it the right time to buy Evoke Pharma Inc. stockMaximize your investment portfolio’s performance - Jammu Links News
When is Evoke Pharma Inc. stock expected to show significant growthExplosive portfolio gains - Jammu Links News
Tools to monitor Evoke Pharma Inc. recovery probabilityFree Earnings Play Trade Plan With Alerts - Newser
Can momentum traders help lift Evoke Pharma Inc.Technical Confirmation System with Signal Alerts - Newser
How does Evoke Pharma Inc. generate profit in a changing economyBuild wealth faster with expert stock selection - Jammu Links News
How volatile is Evoke Pharma Inc. stock compared to the marketOutperformance with explosive growth - Jammu Links News
What is the dividend policy of Evoke Pharma Inc. stockGet daily updates on market movers and shakers - Jammu Links News
What is the risk reward ratio of investing in Evoke Pharma Inc. stockGain the edge with real-time market data - Jammu Links News
Is Evoke Pharma Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
Should I hold or sell Evoke Pharma Inc. stock in 2025Free High-Return Strategy Alerts - Jammu Links News
Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Update - Defense World
What is Evoke Pharma Inc. company’s growth strategyPost Market Watchlist For Every Investor - jammulinksnews.com
Top Risks to Consider Before Buying Evoke Pharma Inc. StockAI Generated Momentum Stock Forecast Guide - Newser
0.43%
0.47%
자본화:
|
볼륨(24시간):